Lunsumio: payments to doctors
Payments that named Lunsumio as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.4M
- Providers
- 4,230
- Transactions
- 8,700
- Average per transaction
- $160
The per-transaction average — $160 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4,230 providers the average total is $328, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Genentech USA, Inc. | $1,229,310 | 88.5% |
| Genentech, Inc. | $159,089 | 11.5% |